Structure |
Chemical Name |
CAS |
MF |
|
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
|
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
|
Ivabradine Impurity 1 Hydrochloride |
85175-52-6 |
C16H25ClN2O3 |
|
SofosBuvir Impurity 3 |
|
|
|
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
|
Canagliflozin Impurity 10 |
1672658-93-3 |
C24H25FO6S |
|
Canagliflozin Impurity F |
|
|
|
Empagliflozin impurity E |
|
|
|
Fasudil Impurity 6 |
2044706-58-1 |
C11H11NO3S |
|
Ibrutinib Impurity 11 |
|
|
|
Nintedanib impurity I |
334951-61-0 |
C30H31N5O4 |
|
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |
|
Everolimus Related Compound 3 |
147438-30-0 |
C32H49NO9 |
|
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1627824-09-2 |
C18H17F5NO5P |
|
Cefuroxime Sodium EP Impurity C |
69822-88-4 |
C15H15N3O6S |
|
Acemetacin EP Impurity F/Carboxymethyl Acemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid |
76812-49-2 |
C23H20ClNO8 |
|
Cefuroxime Sodium EP Impurity G |
97232-98-9 |
C17H17N3O8S |
|
2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone |
1244949-62-9 |
C11H14ClN3O |
|
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile |
1092578-48-7 |
C16H20N6O |
|
4-aMino-5-chloro-2,3-dihydro-N-4-piperidinyl-7-BenzofurancarboxaMide |
137211-64-4 |
C14H18ClN3O2 |
|
(1S,3S,4R)-Entecavir |
1367369-79-6 |
C12H15N5O3 |
|
Prasugrel Impurity III |
1391194-50-5 |
C20H20FNO3S |
|
2-(4-(6-((5-((2-chloro-6-Methylphenyl)carbaMoyl)thiazol-2-yl)aMino)-2-MethylpyriMidin-4-yl)piperazin-1-yl)ethyl acetate |
1245157-85-0 |
C24H28ClN7O3S |
|
Ebastine IMpurity F |
1429071-63-5 |
C32H39NO3 |
|
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-78-2 |
C19H24N4O3 |
|
Azilsartan iMpurity O |
2171316-29-1 |
C23H19N3O4 |
|
cefoxitin iMpurity C |
|
|
|
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile |
1616761-00-2 |
C16H19ClN6O |
|
Aprepitant iMpurity |
96730-04-0 |
C13H22NO4P |
|
Doxofylline iMpurity |
254760-82-2 |
C11H16N4O4 |
|
forMoterol iMpurity |
|
|
|
LevetiracetaM IMpurity 4 |
1342229-32-6 |
C10H19NO4 |
|
cinacalcet iMpurity 4 |
955373-56-5 |
C22H20F3N |
|
Acyclovir IMpurity J |
|
|
|
AzithroMycin IMpurity K |
|
|
|
AztreonaM IMpurity F |
102579-57-7 |
C15H21N5O8S2 |
|
BendaMustine Dideschloroethyl IMpurity |
|
|
|
BroMocriptine IMpurity F |
82773-21-5 |
C32H40BrN5O5 |
|
Cephalexin IMpurity J |
|
C16H17N3O4S |
|
Cetirizine 3-Chloro Impurity |
1232460-31-9 |
C21H25ClN2O3 |
|
Donepezil Impurity 8 |
1808997-65-0 |
C18H23NO4 |
|
Rivaroxaban Impurity 23 |
|
|
|
(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamide |
1450758-21-0 |
C5H6N4O2S |
|
Fosfomycin Trometamol impurity C |
23001-39-0 |
C4H12NO6P |
|
(R)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate |
|
C22H23FN2O5 |
|
1-(7,8-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1822601-94-4 |
C12H15N |
|
Sofosbuvir metabolites |
1859162-80-3 |
C16H18FN2O8P |
|
1,3,5,7-tetrahydroxyadamantane |
16104-28-2 |
C10H16O4 |
|
Cabozantinib Impurity E |
|
|
|
Loxoprofen Impurity I |
|
|
|
Sofosbuvir Impurity22 |
|
|
|
Donepezil Impurity-OH |
148517-82-2 |
C11H12O4 |
|
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one |
13491-41-3 |
C9H13N3O6 |
|
5-(hydroxymethyl)-3-[(5-nitro-2-furyl)methylideneamino]oxazolidin-2-one |
41359-15-3 |
C9H9N3O6 |
|
Cetirizine IMpurity (4-Chlorobenzophenone) |
2724877-99-8 |
C21H25ClN2O3 |
|
Dasatinib IMpurity 3 |
|
|
|
Deferasirox IMpurity 2 |
|
|
|
Desvenlafaxine (O-DesMethyl Venlafaxine) FuMarate |
93414-04-1 |
C20H29NO6 |
|
EzetiMibe Dehydoxy IMpurity |
204589-58-2 |
C24H21F2NO2 |
|
Flurbiprofen IMpurity E |
|
|
|
Levocarnitine IMpurity D |
|
|
|
Montelukast EP IMpurity E |
1187586-58-8 |
C41H46ClNO5S2 |
|
Prasugrel IMpurity 6 |
|
|
|
RebaMipide 2-Chloro IMpurity |
90098-06-9 |
C19H15ClN2O4 |
|
Ribavirin IMp. F (EP) |
|
|
|
RocuroniuM BroMide IMpurity 17 |
|
|
|
SalMeterol IMpurity D |
|
C25H37NO4 |
|
SulbactaM IMpurity A |
|
|
|
Tigecycline Metabolite M6 (9-AniMoMinocycline) |
149934-19-0 |
C23H28N4O7 |
|
VerapaMil IMpurity G |
|
C27H38N2O4 |
|
EthanediaMide iMpurity D |
480452-36-6 |
C21H30ClN5O5 |
|
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
168626-93-5 |
C32H25N3O3 |
|
1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
|
C24H22ClN5O3 |
|
Methyl (4-Methylpiperidin-3-yl)carbaMate |
1204176-45-3 |
C8H16N2O2 |
|
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran |
915095-90-8 |
C17H16BrClO2 |
|
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1358581-37-9 |
C25H27FO6S |
|
Levocarnitine iMpurity |
6490-20-6 |
C7H17ClN2O2 |
|
3-Hydroxy-4-Methyl-2(5H)-thiophenone |
34876-35-2 |
C5H6O2S |
|
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid |
1048973-04-1 |
C24H34O5 |
|
(6α)-17,21-Dihydroxy-6-Methylpregna-1,4,9(11)-triene-3,20-dione |
93269-35-3 |
C22H28O4 |
|
[N(Z)]-N-(3,5-DiMethyl-2(3H)-thiazolylidene)-4-hydroxy-2-Methyl-2H-1,2-benzothiazine-3-carboxaMide 1,1-Dioxide |
1262333-25-4 |
C15H15N3O4S2 |
|
Quetiapine Impurity E |
1371638-05-9 |
C40H44N6O2S2 |
|
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate |
1496551-70-2 |
C31H26ClN3O7 |
|
1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
114262-49-6 |
C10H14N2O6 |
|
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
|
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-(1-ethylpropyl)-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]Methyl]-1-(1H-1,2,4-triazol-1-yl)- |
161532-65-6 |
C37H42F2N8O3 |
|
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one |
186521-85-7 |
C15H19ClO |
|
NSC 351869 |
31350-27-3 |
C14H14N2O4 |
|
4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxybenzamide |
176849-91-5 |
C15H22IN3O2 |
|
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
|
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
|
Doxorubicin Imp B HBr salt |
148218-14-8 |
C29H35Br2NO11 |
|
(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate |
126610-77-3 |
C20H25NO5S |
|
(2R,3R,4R,5S)-5-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-2-(2-hydroxyethyl)tetrahydrofuran-2,3,4-triol |
|
C23H27ClO7 |
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
|
Olaparib iMpurity |
|
|
|
(2S,3R,4R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
|
C21H25ClO6 |
|
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
|
Olaparib iMpurity A |
|
|